|
1.
|
Public omics datasets from sequencing and array-based platforms now amount to millions of samples across thousands of studies and projects. This wealth of data is difficu [...]
2022 |
Dissertation |
|
|
2.
|
The gut microbiome is involved in promoting or inhibiting (protecting against or contributing to the development of) many diseases, such as diabetes, inflammatory bowel d [...]
2023-07-21 |
Abstract |
|
|
3.
|
|
|
4.
|
Tuberculosis remains a major burden on global health infecting an estimated one-third of the world's population. A major obstacle to detecting and overcoming tuberculosis [...]
2012 |
Thesis |
|
|
5.
|
Next-generation sequencing (NGS) technologies have provided opportunities for developing personalized treatments for patients. Given the rapid advances in technology and [...]
2023 |
Thesis |
|
|
6.
|
Immune checkpoint inhibitors have shown success in treating a subset of patients with certain late-stage cancers. However, these treatments fail in many other patients, d [...]
2024 |
Abstract |
|
|
7.
|
Immune checkpoint inhibitors have shown success in treating a subset of patients with certain late-stage cancers. However, these treatments fail in many other patients, d [...]
2023-08-18 |
Abstract |
|
|
8.
|
Contributing to proteomic diversity, alternative splicing of pre-mRNA is widespread in the human transcriptome and can greatly influence regulation of both normal and dis [...]
2020 |
Dissertation |
|
|
9.
|
This inaugural issue includes articles from Dr. Ana Fugolin, D.D.S., M.S, Ph.D. and Dr. Jonathan Baker, Ph.D., based on summaries of their research at the Oregon Health & [...]
2023-12-19 |
Anthology |
|
|
10.
|
Despite decades of conventional chemotherapy, the prognosis for patients with acute myeloid leukemia (AML) remains dismal, with 75% of patients succumbing to their diseas [...]
2021 |
Non-thesis manuscript |
|
